The involvement of immune semaphorins in the pathogenesis of inflammatory bowel diseases (IBDs)

Background and Aims: Immune semaphorins are a large family of proteins involved in the pathogenesis of inflammatory diseases through the regulation of immune homeostasis and tissue inflammation. We aim to assess the possible involvement of semaphorin3A (sema3A) and 4A (sema4A) in peripheral immune responses and bowel tissue inflammation of patients suffering from Crohn's disease (CD) and ulcerative colitis (UC). Patients and Methods: Twenty-seven CD patients and 10 UC patients were studied and compared to 10 patients followed for acute diverticulitis (disease control) and 12 healthy individuals. All were evaluated for sema3A expression on T regulatory cells (T_regs), serum levels of sema3A and sema4A, and tissue expression of sema3A and sema4A in bowel biopsies. Results: The percentage (%) of T regulatory cells (T_regs) expressing sema3A in patients with active CD (64.5% μ14.49%) and active UC (49.8% μ16.45%) was significantly lower when compared to that of healthy controls (88.7% μ3.6%, p< 0.001 and p< 0.0001, respectively). This expression was seen to be in negative correlation with CD activity. Serum levels of Sema4A were significantly lower in patients with CD and UC when compared to that of controls (5.69 μ1.48ng\ml for CD, 5.26μ1.23 ng/ml for UC patients vs 9.74μ2.73ng/ml for normal controls, P<0.001). Sema4A was highly expressed in lymphocytes of the lamina propria of CD and UC patients but absent in patients with diverticulitis or in normal individuals. Conclusions: Altered %of T_regs expressing sema3A in patients with inflammatory bowel diseases (IBD) is partially responsible for their failure in preventing CD4+ effector T cell induced inflammation in IBD in peripheral blood.